METHOD AND SYSTEM FOR MICROBIOME-DERIVED CHARACTERIZATION, DIAGNOSTICS AND THERAPEUTICS FOR CARDIOVASCULAR DISEASE CONDITIONS
Patent №
US 9,754,080
Granted
2017-09-05
Filed 2016
Owner
UBIOME, INC.
Lab
—
AI components
3
nlp · planning · evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15098081
A method for at least one of characterizing, diagnosing, and treating a cardiovascular disease condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the cardiovascular disease condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the cardiovascular disease condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
AI classification
Ownership
UBIOME, INC.
assignment · 383840854
Assignors
ALMONACID, DANIEL, APTE, ZACHARY, RICHMAN, JESSICA, BEHBAHANI, SIAVOSH REZVAN
On an employer assignment, the assignors are typically the inventors.